REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 160 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,157,403 | +188.8% | 100,907 | +537.3% | 0.14% | +94.4% |
| Q2 2023 | $400,733 | -23.5% | 15,833 | -44.2% | 0.07% | -43.2% |
| Q4 2022 | $524,079 | +40.5% | 28,390 | +125.3% | 0.12% | -18.8% |
| Q2 2021 | $373,000 | +119.4% | 12,600 | +16.9% | 0.15% | +83.3% |
| Q1 2019 | $170,000 | – | 10,776 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |